COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications (ACTIV-6)
PI(s): Adrian Hernandez, Duke University; Susanna Naggie, Duke University
Project Summary: The ACTIV-6 study evaluates the effectiveness of currently approved drugs in outpatient participants who have been diagnosed with COVID-19 with mild to moderate symptoms. Approximately 13,000 participants will be enrolled in the ACTIV-6 study. The study will evaluate clinical outcomes in participants in a study drug arm versus those in a placebo arm, comparing approximately 7 different drugs.
Study Design: Multi-CRN Observational Study
Coordinating Center: Duke University
How to Participate: Contact us at email@example.com.